$DVAX Dynavax To update on Covid Vaccine Tuesday

In a regulatory 8-k filing released earlier, the company states: "In meetings with securities analysts and investors to be held on May 19, 2020 in connection with a vaccine investor day, Dynavax intends to provide an update on its early-stage collaborations regarding the potential development of a vaccine for COVID-19 containing the company's proprietary toll-like receptor 9 agonist adjuvant CpG-1018, the adjuvant used in the Company's HEPLISAV-B product. The update is that the company expects that one or more of its collaboration partners will commence a Phase 1 clinical trial of a potential COVID-19 vaccine as soon as July 2020."

Do you want to GAIN an Edge on Wall Street?

1) Sign Up for Free @

2) Follow our Telegram Channel @

3) Join our LIVE CHAT on our Discord @


Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out